DEVICE CIVIL PENALTY PROCESSING DELAYS GIVE FIRMS TIME TO MAKE CORRECTIONS, FDA TELLS REP. BARTON; LEXICOR GETS WAIVER DUE IN PART TO CORRECTIVE ACTIONS
This article was originally published in The Gray Sheet
Device civil penalty processing delays by FDA can benefit companies by giving them time to take corrective actions that could deflect final imposition of the fines, FDA says in a recent letter to Rep. Joe Barton (R-Tex.) responding to the House Commerce/Oversight Subcommittee chairman's inquiry into the agency's civil money penalties program.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.